The European MH Group: Protocol for in Vitro Diagnosis of Susceptibility to MH and Preliminary Results

  • H. Ording


Lack of International agreement on standard test procedures for the diagnosis of malignant hyperthermia susceptibility led to the formation of the European MH Group in 1983. Our group now comprises twelve countries with eighteen test centres meeting regularly. This paper outlines our protocol, specifying how the halothane and the caffeine tests are performed by members of the European MH Group, and compares results obtained in different MH centres.


Malignant Hyperthermia Malignant Hyperthermia Malignant Hyperthermia Susceptibility Standard Test Procedure Tissue Bath 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    European MH Group. Br. J. Anaesth. 1984;56:1267.CrossRefGoogle Scholar
  2. 2.
    Gronert, G.A. Anesth. Analg. 1979;58:367.PubMedGoogle Scholar
  3. 3.
    Ellis, F.R., Harriman, D.G.F., Currie, S. and Cain, P. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune and Stratton, pp. 273–85.Google Scholar
  4. 4.
    Ranklev, E., Fletcher, R. and Blomquist, S. Br. J. Anaesth. 1986;58:646.PubMedCrossRefGoogle Scholar
  5. 5.
    Ording, H. and Skovgaard, L.T. Acta Anaesthesiol. Scand (in press, 1987).Google Scholar
  6. 6.
    European MH Group. Br. J. Anaesth. 1985;57:1038.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • H. Ording
    • 1
  1. 1.The Danish Malignant Hyperthermia Register, Department of AnaesthesiaRigshospitalet University HospitalCopenhagenDenmark

Personalised recommendations